Klinikdirektor Klinische Pharmakologie und Toxikologie

Gastro-Chirurgisches Zentrum
UniversitätsSpital Zürich
Rämistrasse 100
CH-8091 Zürich

eMail	gerd.kullak@usz.ch
Tel.	+41 1 255 20 68
Fax	+41 1 255 44 11

 Publikationsliste

• Beuers U, Kullak-Ublick GA. Therapie chronischer cholestatischer Leberkrankheiten. Der Bayerische Internist 1995; 15: 39-46.
• Kullak-Ublick GA, Beuers U. Cholestatische Leberkrankheiten. Münchener Medizinische Wochenschrift 1996; 138: 133-136.
• Beuers U, Kullak-Ublick GA. Diagnosis and clinical course of cholestatic liver diseases. In: Progress in Hepato-Pharmacology, Vol. II, 1997: 29-34.
• He C, Fischer S, Kullak-Ublick GA, Domingo N, Lafont H, Jüngst D. Electrophoretic analysis of proteins in bile. Anal Chim Acta 1999; 383: 185-203.
• Kullak-Ublick GA. Regulation of organic anion and drug transporters of the sinusoidal membrane. J Hepatol 1999; 31: 563-573.
• Kullak-Ublick GA, Meier PJ. Mechanisms of cholestasis. Clinics in Liver Disease [Clinics of North America] 2000; 4: 357-385.
• Kullak-Ublick GA, Beuers U, Paumgartner G. Hepatobiliary transport. J Hepatol 2000; 32 (Suppl. 1): 3-18.
• Kullak-Ublick GA, Stieger B, Hagenbuch B, Meier PJ. Hepatic transport of bile salts. Semin Liver Dis 2000; 20: 273-292.
• St.-Pierre MV, Kullak-Ublick GA, Hagenbuch B, Meier PJ. Bile acid transport in hepatic and non-hepatic tissues. J Exp Biol 2001; 204: 1673-1686.
• Stanca C, Jung D, Meier PJ, Kullak-Ublick GA. Hepatocellular transport proteins and their role in liver disease. World J Gastroentero 2001; 7: 157-169.

• Heinemann T, Pietruck B, Kullak-Ublick G, von Bergmann K. Comparison of sitosterol and sitostanol on inhibition of intestinal cholesterol absorption. Agents Actions 1988; 26: S117-S122.
• Meier PJ, Hagenbuch B, Stieger B, Kullak-Ublick G, Jacquemin E. Molecular properties of two basolateral bile acid and organic anion transporters of rat and human liver. In: Keppler D, Jungermann K (eds.). Transport in the Liver. Dordrecht, Boston, London: Kluwer Academic Publishers, 1994: 39-48.
• Beuers U, Kullak-Ublick GA, Paumgartner G. Bile acids and hepatocellular signalling. In: Beuers U, Paumgartner G (eds.). Bile Acids in Liver Diseases. Dordrecht, Boston, London: Kluwer Academic Publishers, 1995: 96-100.
• Beuers U, Kullak-Ublick GA. Bile Acids in Liver Diseases: Congress Short Report. Freiburg: Falk Foundation e.V., 1995.
• Beuers U, Kullak-Ublick GA. Cholestasis and the bone. In: Broelsch CE, Burdelski M, Rogiers X (eds.). Cholestatic Liver Diseases in Children and Adults. Dordrecht, Boston, London: Kluwer Academic Publishers, 1996: 64-70.
• Beuers U, Kullak-Ublick GA, Paumgartner G. Mechanism of action of UDCA in cholestatic syndromes. In: Alvaro D, Benedetti A, Strazzabosco M (eds.). Vanishing Bile Duct Syndrome: Pathophysiology and Treatment. Dordrecht, Boston, London: Kluwer Academic Publishers, 1997: 230-239.
• Kullak-Ublick GA, Beuers U, Meier PJ, Wolkoff AW, Paumgartner G. Regulation of the organic anion transporting polypeptide of human liver. In: Paumgartner G, Stiehl A, Gerok W (eds.). Bile Acids in Hepatobiliary Diseases - Basic Research and Clinical Application. Dordrecht, Boston, London: Kluwer Academic Publishers, 1997: 104-106.
• Beuers U, Kullak-Ublick GA, Paumgartner G. Modulation of hepatocellular signaling by bile acids. In: Paumgartner G, Stiehl A, Gerok W (eds.). Bile Acids in Hepatobiliary Diseases - Basic Research and Clinical Application. Dordrecht, Boston, London: Kluwer Academic Publishers, 1997: 213-218.
• Kullak-Ublick GA, Oswald M, Meier PJ, Beuers U, Paumgartner G. Regulation of basolateral bile acid transport proteins in human liver. In: Paumgartner G, Stiehl A, Gerok W, Keppler D, Leuschner U (eds.). Bile Acids and Cholestasis. Dordrecht, Boston, London: Kluwer Academic Publishers, 1999: 95-101.
• Beuers U, Probst I, Soroka C, Boyer JL, Kullak-Ublick GA, Paumgartner G. Concentration-dependent modulation of cytosolic free calcium and protein kinase C by taurolithocholic acid in isolated rat hepatocytes. In: Paumgartner G, Stiehl A, Gerok W, Keppler D, Leuschner U (eds.). Bile Acids and Cholestasis. Dordrecht, Boston, London: Kluwer Academic Publishers, 1999: 151-155.
• Beuers U, Kullak-Ublick GA. Diseases of the Liver and the Bile Ducts ­ New Aspects and Clinical Implications: Congress Short Report, Falk Symposium 107. Freiburg: Falk Foundation e.V., 1999.
• Kullak-Ublick GA, Beuers U. Bile Acids and Cholestasis: Congress Short Report, Falk Symposium 108. Freiburg: Falk Foundation e.V., 1999.
• Kullak-Ublick GA. Molekulare Hepatologie: Was ist praxisrelevant? Hämochromatose und Alpha-1-Antitrypsin-Mangel. Ars Medici 2000; 9: 558-560.
• Kullak-Ublick GA, Ismair M, Hagenbuch B, Meier PJ. Drug and steroid clearance by the hepatic organic anion transporting protein family. In: Gerbes AL, Beuers U, Jüngst D, Pape GR, Sackmann M, Sauerbruch T (eds.). Hepatology 2000. Dordrecht, Boston, London: Kluwer Academic Publishers, 2000: 5-12.
• Kullak-Ublick GA, Stieger B, Fattinger K, Meier PJ. Cholestasis induced by drugs and toxins. In: Acalovschi M, Paumgartner G (eds.). Hepatobiliary Diseases: Cholestasis and Gallstones. Dordrecht, Boston, London: Kluwer Academic Publishers, 2000: 48-53.
• Fattinger K, Roos M, Spiess A, Vergères P, Braunschweig S, Kullak-Ublick GA, Galeazzi RL, Follath F, Schaffner A, Gasser T, Meier-Abt PJ. Die «Stiftung für Arzneimittelsicherheit» SAS/CHDM: Update 2000. Multifunktionale Anwendungen einer pharmakoepidemiologischen Datenbank zur Erfassung von unerwünschten Arzneimittelwirkungen und zur Optimierung der Pharmakotherapie im Spital. Schweiz Ärztezeitung 2000: 81:2381-2384.
• Kullak-Ublick GA, Jung D, Ismair MG, Meier PJ. Uptake of drugs into the liver. In: Boyer JL, Keppler D, Matern S, Meier-Abt PJ (eds.). Hepatobiliary Transport: From Bench to Bedside. Dordrecht, Boston, London: Kluwer Academic Publishers, 2001: [in press].
• Kullak-Ublick GA. Drug-induced cholestatic liver disease. In: Trauner M, Jansen PLM (eds.). Molecular Pathogenesis of Cholestasis. Austin/Texas: Landes Bioscience, 2001: [in preparation].